Immunomodulatory compounds and treatment of diseases related...

Details Immunomodulatory compounds and treatment of diseases related... Immunomodulatory compounds and treatment of diseases related...

2011-03-29

2011-03-29

Cordero Garcia, Marcela M (Department: 1654)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Phosphorus containing other than solely as part of an...

Reexamination Certificate

active

07915240

ABSTRACT:
Method of using immunomodulatory compounds for treating diseases related to an overproduction of inflammatory cytokines, including diseases selected from asthma, atopic dermatitis, allergic rhinitis, prostatitis, inflammatory bowel disease, diabetes, and rhumatoid arthritis, the compounds being of general formula (I):wherein:m and n, independently from each other, are an integer ranging from 1 to 4,X and Y represent —COOH, —O—P(O)(OH)2, —O—SO2(OH), —NH2, —OH, —CONH(CH2)n1—NH2, —CO—NH—CH(COOH)—(CH2)n1—COOH, —CO—NH—CH(COOH)—(CH2)n1—NH2, —O—CO—(CH2)n1—NH2, —O—CO—(CH2)n1—CHOH—CH2OH, —O—CO—(CH2)n1—OH, —O—CO—(CH2)n1—COOH, —O—CO—(CH2)n1—CHO, —O—CO—(CH2)n1—NH—CO—(CH2)n2—COOH,R1and R2each designate an acyl group derived from a saturated or unsaturated, straight- or branched-chain carboxylic acid having from 2 to 18 carbon atoms, which is unsubstituted or bears one to three substituents selected among hydroxyl, dihydroxyphosphoryloxy, alkyl of 2 to 18 carbon atoms, alkoxy of 2 to 18 carbon atoms, acyloxy of 2 to 18 carbon atoms in the acyl moiety, amino, acylamino.

REFERENCES:
patent: 6297257 (2001-10-01), Napoletano et al.
patent: 6831069 (2004-12-01), Tam et al.
patent: 7157092 (2007-01-01), Bauer et al.
patent: 7799762 (2010-09-01), Bauer et al.
patent: 2003/0203852 (2003-10-01), Bauer et al.
patent: 2005/0192232 (2005-09-01), Bauer et al.
patent: 2006/0148678 (2006-07-01), Bauer et al.
patent: 20220947 (2002-02-01), None
patent: 1081132 (1999-05-01), None
patent: 1 081 132 (2004-03-01), None
patent: 2051728 (2009-04-01), None
patent: WO00/00462 (2000-12-01), None
patent: WO 01/46127 (2001-06-01), None
patent: WO 01/57233 (2001-08-01), None
patent: WO 01/57233 (2001-08-01), None
Frieri. Nitric Oxide in Allergic Rhinitis and Asthma. Allergy and Asthma Proceedings. 1998, No. 19, pp. 349-351.
Chan et al. Nitric oxide and vascular responses in Type I diabetes. Diabetologia. 2000. vol. 43, pp. 137-147.
Taniuchi et al. Increased serum nitrate levels in infants with atopic dermatitis. Allergy, 2001. vol. 56, pp. 693-695.
EPO machine language translation from German to English for DE 20220947, Feb. 2002, 29 pages.
Byl et al., “OM197-MP-AC induces the maturation of human dendritic cells and promotes a primary T cell responce,” Int. Immunopharm., vol. 3, pp. 417-425 (2003).
European Communication Pursuant to Article 94(3) EPC, Apr. 12, 2010, for OM Pharma, European Application No. 07733936.4, filed Mar. 9, 2007.

Affiliated with

Also associated with

Rating

Immunomodulatory compounds and treatment of diseases related... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Immunomodulatory compounds and treatment of diseases related..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunomodulatory compounds and treatment of diseases related... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2746143